Recombinant DNA

#AAV #Gene therapy #Genetics / genomics #Genome sequencing #Recombinant DNA #Webinar

How can long-read nanopore sequencing support gene therapy delivery?

Join DDW for this exclusive free event, ‘rAAV genome sequencing with Oxford Nanopore uncovers transgene integrity and packaging impurities’. The event will be supported by Oxford Nanopore Technologies. The event will feature experts Daniel Jachimowicz, Senior Bioscience Scientist at AstraZeneca BioPharmaceuticals R&D, Sweden,… Read More

Webinar date:
Supported by Oxford Nanopore Technologies
#News

#AAV #Gene therapy #Genetics / genomics #Genome sequencing #Recombinant DNA #Webinar

Uncovering packaging impurities with rAAV genome sequencing

Join DDW for this exclusive free event, ‘rAAV genome sequencing with Oxford Nanopore uncovers transgene integrity and packaging impurities’. The event will be supported by Oxford Nanopore Technologies. The event will feature experts Daniel Jachimowicz, Senior Bioscience Scientist at AstraZeneca BioPharmaceuticals R&D, Sweden,… Read More

Webinar date:
Supported by Oxford Nanopore Technologies
#News

Gene sequence
#AAV #Gene therapy #Genetics / genomics #Genome sequencing #Recombinant DNA

How rAAV genome sequencing uncovers transgene integrity

Join DDW for this exclusive free event, ‘rAAV genome sequencing with Oxford Nanopore uncovers transgene integrity and packaging impurities’. The event will be supported by Oxford Nanopore Technologies. The event will feature experts Daniel Jachimowicz, Senior Bioscience Scientist at AstraZeneca BioPharmaceuticals R&D, Sweden,… Read More

Webinar date:
Supported by Oxford Nanopore Technologies
#News

#AAV #Gene therapy #Genetics / genomics #Genome sequencing #Recombinant DNA

DDW event focusses on rAAVs and long-read nanopore sequencing

Join DDW for this exclusive free event, ‘rAAV genome sequencing with Oxford Nanopore uncovers transgene integrity and packaging impurities’. The event will be supported by Oxford Nanopore Technologies. The event will feature experts Daniel Jachimowicz, Senior Bioscience Scientist at AstraZeneca BioPharmaceuticals R&D, Sweden,… Read More

Webinar date:
Supported by Oxford Nanopore Technologies
#News

#AAV #Gene therapy #Genetics / genomics #Genome sequencing #Recombinant DNA

rAAV Genome sequencing uncovers transgene integrity and packaging impurities

Recombinant adeno-associated viruses (rAAVs) are considered a promising delivery system for gene therapy medicines. This webinar highlights how long-read nanopore sequencing as a comprehensive and sensitive QC method for rAAVs were evaluated — which is supporting internal research activities at AstraZeneca. You will hear how library preparation, assessed data quality,… Read More

Webinar date:
Supported by Oxford Nanopore Technologies
#Webinars

#DNA technology #Drug discovery #Podcast #Recombinant DNA #Target identification #Target validation

Recombinant DNA technology and its impact on drug discovery: Podcast

The latest DDW Sitting Down With sponsored podcast features Yuning Chen, Senior R&D Manager at Sino Biological. Recombinant production is a field in which Sino Biological has extensive expertise – the company boasts several platforms to use recombinant DNA technology for the manufacturing of a variety of proteins and… Read More

#News

#DNA technology #Drug discovery #Podcast #Recombinant DNA #Sitting Down With #Target identification #Target validation

Recombinant DNA technology and its impact on modern drug discovery

The latest DDW Sitting Down With sponsored podcast features Yuning Chen, Senior R&D Manager at Sino Biological. Recombinant production is a field in which Sino Biological has extensive expertise – the company boasts several platforms to use recombinant DNA technology for the manufacturing of a variety of proteins and… Read More

#Podcasts